Advertisement
There is evidence for co-occurrence and coaggregation of asthma and type 1 diabetes in children and their siblings

Evidence Shows Co-Occurrence, Coaggregation of Asthma, T1DM

0
Children with asthma and their siblings have increased subsequent risk for type 1 diabetes
Children with food protein-induced enterocolitis syndrome have higher rates of atopic comorbidity

Atopic Comorbidity Up in Children With Food Protein-Induced Enterocolitis

0
Higher rates seen for atopic dermatitis, IgE-mediated food allergy, asthma, allergic rhinitis
Average employer-sponsored insurance spending rose to $5

2018 Health Care Spending Up Due to Higher Prices

0
2018 uptick in utilization first seen in years, but impact dwarfed by price increases
There are significant sex differences in salaries of clinical department chairs in public medical schools in the United States

Female Clinical Chairs Paid Significantly Less Than Men

0
Findings based on study of 550 clinical department chairs at 29 public U.S. medical schools
Asthma and allergy drug montelukast -- sold as a generic and under the brand name Singulair -- will get a "boxed warning" over potential ties to neuropsychiatric effects

FDA: Singulair to Get ‘Black Box’ Warning

0
Drug has long carried warning of potentially dangerous neuropsychiatric side effects
From 2007 to 2018

Considerable Increase Seen in List, Net Prices of Branded Drugs

0
From 2007 to 2018, list prices increased 159 percent, while net prices increased by 60 percent
Since the implementation of coverage expansions associated with the Affordable Care Act

Racial/Ethnic Insurance Coverage Disparity Down Since ACA

0
From 2013 to 2017, drop seen in unadjusted, adjusted black-white gap, Hispanic-white gap in uninsurance
From 1996 to 2016

1996 to 2016 Saw Increases in U.S. Spending on Health Care

0
Public, private insurance, out-of-pocket payments increased by 2.9, 2.6, and 1.1 percent annually

February 2020 Briefing – Allergy

0
Here are what the editors at HealthDay consider to be the most important developments in Allergy for February 2020. This roundup includes the latest...
For patients with refractory chronic cough or unexplained chronic cough

Gefapixant Promising for Relief of Unexplained Chronic Cough

0
Cough frequency significantly reduced after 12 weeks of gefapixant 50 mg versus placebo in phase 2b study